Placing preterm infants on their back or in recovery position on their left side at birth

A randomised trial of placing preterm infants on their back or in recovery position on their left side at birth

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN74486341

Enrollment

Registered

2012-10-16

Start date

2012-10-19

Completion date

Unknown

Last updated

2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prematurity, respiratory distress syndrome Neonatal Diseases Other preterm infants

Interventions

Placement in the recovery position on the left side or on their back

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Infants born at the NMH at < 32 weeks gestation (i.e. up to 31+6 weeks)

Exclusion criteria

Exclusion criteria: Infants with a major congenital anomaly, for example: 1. Diaphragmatic hernia 2. Cardiac anomaly other than patent ductus arteriosus 3. Ventricular septal defect or atrial septal defect 4. Gastroschisis 5. Omphalocoele 6. Oesophageal atresia with tracheo-oesophageal fistula Pierre-Robin sequence

Design outcomes

Primary

Measure	Time frame
Oxygen saturation (SpO2) measured pre-ductally (i.e. from the right upper limb) at 5 minutes of life	—

Secondary

Measure	Time frame
1. Heart rate (HR) at 5 minutes 2. SpO2 at 10 minutes 3. HR at 10 minutes 4. Apgar score at 1 minute 5. Apgar score at 5 minutes 6. Apgar score at 10 minutes 7. Time to SpO2 > 90% 8. HR 30% oxygen in the DR 13. Maximum FiO2 in the DR 14. Intubation in the DR 15. Chest compressions in the DR 16. Volume resuscitation in the DR 17. Intubation during hospitalisation 18.Surfactant use 19. Duration of ventilation (hours) 20. Duration of CPAP (days) 21. Postnatal corticosteroid use 22. Bronchopulmonary dysplasia ¨C oxygen therapy at 28 days of life 23. Chronic lung disease oxygen therapy at 36 week's postmenstrual age 24. Cranial ultrasound abnormalities (intraventricular haemorrhage, cystic PVL, ventricular dilatation) 25. Medical treatment for PDA 26. PDA ligation 27. NEC Bells stage 2 28. Retinopathy of prematurity 29. Duration of hospital stay 30. Death before discharge from hospital	—

Measure

Time frame

1. Heart rate (HR) at 5 minutes 2. SpO2 at 10 minutes 3. HR at 10 minutes 4. Apgar score at 1 minute 5. Apgar score at 5 minutes 6. Apgar score at 10 minutes 7. Time to SpO2 > 90% 8. HR 30% oxygen in the DR 13. Maximum FiO2 in the DR 14. Intubation in the DR 15. Chest compressions in the DR 16. Volume resuscitation in the DR 17. Intubation during hospitalisation 18.Surfactant use 19. Duration of ventilation (hours) 20. Duration of CPAP (days) 21. Postnatal corticosteroid use 22. Bronchopulmonary dysplasia ¨C oxygen therapy at 28 days of life 23. Chronic lung disease oxygen therapy at 36 week's postmenstrual age 24. Cranial ultrasound abnormalities (intraventricular haemorrhage, cystic PVL, ventricular dilatation) 25. Medical treatment for PDA 26. PDA ligation 27. NEC Bells stage 2 28. Retinopathy of prematurity 29. Duration of hospital stay 30. Death before discharge from hospital

—

Countries

Ireland

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 2, 2026